File Archive - Ecstasy (MDMA, MDEA, MDA) Documents - Serotonin 5-HT2B receptors are required for 3,4-methylenedioxymethamphetamine-induced hyperlocomotion and 5-HT release in vivo and in vitro (2008) - Drugs Forum
Drugs-Forum  
News Groups Blog Forum Chat Video Audio Images Documents Wiki Home
Go Back   Drugs Forum > File Archive > Documents > CHEMICAL & (SEMI-) SYNTHETIC DRUGS > Ecstasy (MDMA, MDEA, MDA) Documents
Register Tags Mark Forums Read

Notices

Search
links

 
Ecstasy (MDMA, MDEA, MDA) Documents
Documents about MDMA, MDEA, MDA, XTC, E
New entries announced in forum Ecstasy (MDMA, MDEA, MDA)
Allowances: 4.88 Mbytes/132.33 Kbytes used

  Entries
  Serotonin 5-HT2B receptors are required for 3,4-methylenedioxymethamphetamine-induced hyperlocomotion and 5-HT release in vivo and in vitro (2008) Left click: open entry/Right click: save entry
Journal of Neuroscience 2008 Mar 12,28(11):2933-2940

Doly S, Valjent E, Setola V, Callebert J, Hervé D, Launay JM, Maroteaux L

The "club drug" 3,4-methylenedioxymethamphetamine (MDMA; also known as ecstasy) binds preferentially to and reverses the activity of the serotonin transporter, causing release of serotonin [5-hydroxytryptamine (5-HT)] stores from nerve terminals. Subsequent activation of postsynaptic 5-HT receptors by released 5-HT has been shown to be critical for the unique psychostimulatory effects of MDMA. In contrast, the effects of direct activation of presynaptic and/or postsynaptic receptors by MDMA have received far less attention, despite the agonist actions of the drug itself at 5-HT(2) receptors, in particular the 5-HT(2B) receptor. Here we show that acute pharmacological inhibition or genetic ablation of the 5-HT(2B) receptor in mice completely abolishes MDMA-induced hyperlocomotion and 5-HT release in nucleus accumbens and ventral tegmental area. Furthermore, the 5-HT(2B) receptor dependence of MDMA-stimulated release of endogenous 5-HT from superfused midbrain synaptosomes suggests that 5-HT(2B) receptors act, unlike any other 5-HT receptor, presynaptically to affect MDMA-stimulated 5-HT release. Thus, our findings reveal a novel regulatory component in the actions of MDMA and represent the first demonstration that 5-HT(2B) receptors play an important role in the brain, i.e., modulation of 5-HT release. As such, 5-HT(2B) receptor antagonists may serve as promising therapeutic drugs for MDMA abuse.

Discussion Thread

Category Ecstasy (MDMA, MDEA, MDA) Documents 
 
Suggest other entries I might like
Submitted by Jatelka Find all entries from this user
20-03-2008
630.01 Kbytes Hits 6
Keywords: ecstasy 5ht-2b mdma serotonin
 

 
Category
 
Forum Jump

Sitelinks: Site Functions:

All times are GMT +1. The time now is 12:32.


Copyright: Substance Information Network 2003 - 2009, All rights reserved